Feasibility, Safety, and Efficacy of Posterior Wall Isolation During Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis.


Journal

Circulation. Arrhythmia and electrophysiology
ISSN: 1941-3084
Titre abrégé: Circ Arrhythm Electrophysiol
Pays: United States
ID NLM: 101474365

Informations de publication

Date de publication:
08 2019
Historique:
entrez: 13 8 2019
pubmed: 14 8 2019
medline: 9 4 2020
Statut: ppublish

Résumé

The posterior left atrium is an arrhythmogenic substrate that contributes to the initiation and maintenance of atrial fibrillation (AF); however, the feasibility, safety, and efficacy of posterior wall isolation (PWI) as an AF ablation strategy has not been widely reported. We undertook a systematic review and meta-analysis of studies performing PWI to assess (1) acute procedural success including the ability to achieve PWI and the number of procedure-related complications, (2) Long-term, clinical success including rates of arrhythmia recurrence and posterior wall reconnection, and (3) The efficacy of PWI compared with pulmonary vein isolation on preventing arrhythmia recurrence. MEDLINE, EMBASE, and Web of Science databases were searched in May 2018 to retrieve relevant studies. Results were pooled using a random effects model. Seventeen studies (13 box isolation, 3 single ring isolation, and 1 debulking ablation) comprising 1643 patients (31.3% paroxysmal AF, left atrial diameter 41±3.1 mm) were included in the final analysis. In studies focusing specifically on PWI, the acute procedural success rate for achieving PWI was 94.1% (95% CI, 87.2%-99.3%). Single-procedure 12-month freedom from atrial arrhythmia was 65.3% (95% CI, 57.7%-73.9%) overall and 61.9% (54.2%-70.8%) for persistent AF. Randomized control trials comparing PWI to pulmonary vein isolation (3 studies, 444 patients) yielded conflicting results and could not confirm an incremental benefit to PWI. Fifteen major complications (0.1%), including 2 atrio-esophageal fistulas, were reported. PWI as an end point of AF ablation can be achieved in a large proportion of cases with good rates of 12-month freedom from atrial arrhythmia. Although the procedure-related complication rate is low, it did not eliminate the risk of atrio-esophageal fistula. Registration: URL: http://www.crd.york.ac.uk/prospero. PROSPERO registration number: CRD42018107212.

Sections du résumé

BACKGROUND
The posterior left atrium is an arrhythmogenic substrate that contributes to the initiation and maintenance of atrial fibrillation (AF); however, the feasibility, safety, and efficacy of posterior wall isolation (PWI) as an AF ablation strategy has not been widely reported.
METHODS
We undertook a systematic review and meta-analysis of studies performing PWI to assess (1) acute procedural success including the ability to achieve PWI and the number of procedure-related complications, (2) Long-term, clinical success including rates of arrhythmia recurrence and posterior wall reconnection, and (3) The efficacy of PWI compared with pulmonary vein isolation on preventing arrhythmia recurrence. MEDLINE, EMBASE, and Web of Science databases were searched in May 2018 to retrieve relevant studies. Results were pooled using a random effects model.
RESULTS
Seventeen studies (13 box isolation, 3 single ring isolation, and 1 debulking ablation) comprising 1643 patients (31.3% paroxysmal AF, left atrial diameter 41±3.1 mm) were included in the final analysis. In studies focusing specifically on PWI, the acute procedural success rate for achieving PWI was 94.1% (95% CI, 87.2%-99.3%). Single-procedure 12-month freedom from atrial arrhythmia was 65.3% (95% CI, 57.7%-73.9%) overall and 61.9% (54.2%-70.8%) for persistent AF. Randomized control trials comparing PWI to pulmonary vein isolation (3 studies, 444 patients) yielded conflicting results and could not confirm an incremental benefit to PWI. Fifteen major complications (0.1%), including 2 atrio-esophageal fistulas, were reported.
CONCLUSIONS
PWI as an end point of AF ablation can be achieved in a large proportion of cases with good rates of 12-month freedom from atrial arrhythmia. Although the procedure-related complication rate is low, it did not eliminate the risk of atrio-esophageal fistula. Registration: URL: http://www.crd.york.ac.uk/prospero. PROSPERO registration number: CRD42018107212.

Identifiants

pubmed: 31401853
doi: 10.1161/CIRCEP.118.007005
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e007005

Auteurs

Anand Thiyagarajah (A)

Centre for Heart Rhythm Disorders, University of Adelaide, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., R.M., V.M., C.O., R.M., P.S.).
Department of Cardiology, Royal Adelaide Hospital, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., V.M., C.O., R.M., P.S.).

Kadhim Kadhim (K)

Centre for Heart Rhythm Disorders, University of Adelaide, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., R.M., V.M., C.O., R.M., P.S.).
Department of Cardiology, Royal Adelaide Hospital, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., V.M., C.O., R.M., P.S.).

Dennis H Lau (DH)

Centre for Heart Rhythm Disorders, University of Adelaide, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., R.M., V.M., C.O., R.M., P.S.).
Department of Cardiology, Royal Adelaide Hospital, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., V.M., C.O., R.M., P.S.).

Mehrdad Emami (M)

Centre for Heart Rhythm Disorders, University of Adelaide, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., R.M., V.M., C.O., R.M., P.S.).
Department of Cardiology, Royal Adelaide Hospital, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., V.M., C.O., R.M., P.S.).

Dominik Linz (D)

Centre for Heart Rhythm Disorders, University of Adelaide, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., R.M., V.M., C.O., R.M., P.S.).
Department of Cardiology, Royal Adelaide Hospital, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., V.M., C.O., R.M., P.S.).

Kashif Khokhar (K)

Centre for Heart Rhythm Disorders, University of Adelaide, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., R.M., V.M., C.O., R.M., P.S.).
Department of Cardiology, Royal Adelaide Hospital, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., V.M., C.O., R.M., P.S.).

Dian A Munawar (DA)

Centre for Heart Rhythm Disorders, University of Adelaide, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., R.M., V.M., C.O., R.M., P.S.).
Department of Cardiology, Royal Adelaide Hospital, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., V.M., C.O., R.M., P.S.).

Ricardo Mishima (R)

Centre for Heart Rhythm Disorders, University of Adelaide, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., R.M., V.M., C.O., R.M., P.S.).
Department of Cardiology, Lyell McEwin Health Service, Adelaide, Australia (R.M.).

Varun Malik (V)

Centre for Heart Rhythm Disorders, University of Adelaide, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., R.M., V.M., C.O., R.M., P.S.).
Department of Cardiology, Royal Adelaide Hospital, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., V.M., C.O., R.M., P.S.).

Catherine O'Shea (C)

Centre for Heart Rhythm Disorders, University of Adelaide, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., R.M., V.M., C.O., R.M., P.S.).
Department of Cardiology, Royal Adelaide Hospital, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., V.M., C.O., R.M., P.S.).

Rajiv Mahajan (R)

Centre for Heart Rhythm Disorders, University of Adelaide, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., R.M., V.M., C.O., R.M., P.S.).
Department of Cardiology, Royal Adelaide Hospital, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., V.M., C.O., R.M., P.S.).

Prashanthan Sanders (P)

Centre for Heart Rhythm Disorders, University of Adelaide, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., R.M., V.M., C.O., R.M., P.S.).
Department of Cardiology, Royal Adelaide Hospital, Adelaide, Australia (A.T., K. Kadhim, D.H.L., M.E., D.L., K. Khokhar, D.A.M., V.M., C.O., R.M., P.S.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH